Target intelligence / Profile preview

Calcium ions in amorphous calcium phosphate clusters (ACP)

Target
ACP
Molecular classification
Inorganic mineral, Other
01

Overview

Amorphous calcium phosphate (ACP) is a non-crystalline, metastable phase of calcium phosphate that serves as a vital intermediate in the formation of hydroxyapatite, the primary inorganic constituent of bone and teeth (Dey et al., 2010, Nature Materials). Within these amorphous clusters, often referred to as Posner's clusters (Ca9(PO4)6), calcium ions are held in a highly reactive and labile state, allowing for rapid release and transformation into crystalline mineral phases (Posner & Betts, 1975, Accounts of Chemical Research). Biologically, these clusters are essential for the controlled mineralization of the extracellular matrix, acting as a reservoir that prevents premature crystallization while ensuring a local supersaturation of ions (Habraken et al., 2013, Nature Communications). In therapeutic contexts, ACP is primarily utilized in dentistry, where it is often stabilized by casein phosphopeptides (CPP-ACP) to treat dental caries and white spot lesions by promoting enamel remineralization (Reynolds, 2008, Journal of Dental Research). The calcium ions released from these clusters interact with fluoride and phosphate to rebuild the mineral structure of the tooth, effectively reversing early-stage decay. Furthermore, ACP-based materials are employed in orthopedic applications as osteoconductive scaffolds that enhance bone regeneration and the integration of implants (Zhao et al., 2011, Biomaterials).

Other names
Amorphous calcium phosphatePosner's clustersNon-crystalline calcium phosphateACP clusters
02

Mechanism of action

Provides a labile source of calcium and phosphate ions to maintain mineral supersaturation and promote the formation of hydroxyapatite in hard tissues.

03

Biological functions

BiomineralizationOther
04

Disease associations

Dental cariesOther
05

Safety considerations

Ectopic calcificationPotential for rapid transformation to crystalline phasesBioavailability in different pH environments
06

Interacting drugs

Casein phosphopeptide-amorphous calcium phosphate (CPP-ACP)

1 more in the full profile.

07

Biomarkers

Salivary calcium levelsBone mineral density

Beyond the preview

Go deeper on Calcium ions in amorphous calcium phosphate clusters (ACP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Calcium ions in amorphous calcium phosphate clusters (ACP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call